South Korea · Delayed Price · Currency is KRW SANDS LAB Statistics
Total Valuation
SANDS LAB has a market cap or net worth of KRW 84.12 billion. The enterprise value is 54.24 billion.
| Market Cap | 84.12B |
| Enterprise Value | 54.24B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
SANDS LAB has 15.27 million shares outstanding. The number of shares has increased by 3.57% in one year.
| Current Share Class | 15.27M |
| Shares Outstanding | 15.27M |
| Shares Change (YoY) | +3.57% |
| Shares Change (QoQ) | -0.37% |
| Owned by Insiders (%) | 17.64% |
| Owned by Institutions (%) | n/a |
| Float | 6.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.96 |
| PB Ratio | 1.70 |
| P/TBV Ratio | 1.80 |
| P/FCF Ratio | 122.75 |
| P/OCF Ratio | 78.14 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 133.44, with an EV/FCF ratio of 79.15.
| EV / Earnings | n/a |
| EV / Sales | 5.13 |
| EV / EBITDA | 133.44 |
| EV / EBIT | n/a |
| EV / FCF | 79.15 |
Financial Position
The company has a current ratio of 9.33, with a Debt / Equity ratio of 0.00.
| Current Ratio | 9.33 |
| Quick Ratio | 8.69 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | -3,859.09 |
Financial Efficiency
Return on equity (ROE) is -3.49% and return on invested capital (ROIC) is -3.89%.
| Return on Equity (ROE) | -3.49% |
| Return on Assets (ROA) | -0.90% |
| Return on Invested Capital (ROIC) | -3.89% |
| Return on Capital Employed (ROCE) | -1.61% |
| Weighted Average Cost of Capital (WACC) | 9.66% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.19 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SANDS LAB has paid 152.58 million in taxes.
| Income Tax | 152.58M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.98% in the last 52 weeks. The beta is 0.98, so SANDS LAB's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | -39.98% |
| 50-Day Moving Average | 4,020.80 |
| 200-Day Moving Average | 6,026.13 |
| Relative Strength Index (RSI) | 76.42 |
| Average Volume (20 Days) | 229,078 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SANDS LAB had revenue of KRW 10.56 billion and -1.89 billion in losses. Loss per share was -123.24.
| Revenue | 10.56B |
| Gross Profit | 10.56B |
| Operating Income | -794.97M |
| Pretax Income | -1.64B |
| Net Income | -1.89B |
| EBITDA | 406.49M |
| EBIT | -794.97M |
| Loss Per Share | -123.24 |
Balance Sheet
The company has 30.10 billion in cash and 3.58 million in debt, with a net cash position of 30.10 billion or 1,971.40 per share.
| Cash & Cash Equivalents | 30.10B |
| Total Debt | 3.58M |
| Net Cash | 30.10B |
| Net Cash Per Share | 1,971.40 |
| Equity (Book Value) | 49.48B |
| Book Value Per Share | 3,223.20 |
| Working Capital | 30.69B |
Cash Flow
In the last 12 months, operating cash flow was 1.08 billion and capital expenditures -391.31 million, giving a free cash flow of 685.33 million.
| Operating Cash Flow | 1.08B |
| Capital Expenditures | -391.31M |
| Depreciation & Amortization | 1.20B |
| Net Borrowing | -10.59M |
| Free Cash Flow | 685.33M |
| FCF Per Share | 44.89 |
Margins
Gross margin is 100.00%, with operating and profit margins of -7.53% and -17.84%.
| Gross Margin | 100.00% |
| Operating Margin | -7.53% |
| Pretax Margin | -15.56% |
| Profit Margin | -17.84% |
| EBITDA Margin | 3.85% |
| EBIT Margin | -7.53% |
| FCF Margin | 6.49% |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 3.65%.
| Dividend Per Share | 150.00 |
| Dividend Yield | 3.65% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.57% |
| Shareholder Yield | 0.09% |
| Earnings Yield | -2.24% |
| FCF Yield | 0.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SANDS LAB has an Altman Z-Score of 19.95 and a Piotroski F-Score of 2.
| Altman Z-Score | 19.95 |
| Piotroski F-Score | 2 |